See how Bambanker™ supports high post-thaw recovery and reliable downstream performance across tissues, organoids, tumor ...
Paradigm Health today announced SPIRE -- Scalable Platform for Integrated Research & Evidence -- a new model for post-approval and late-stage clinical studies designed to help sponsors generate ...
LAPNET-01 Phase 1b study shows netrin-1 blockade may overcome and prevent chemoresistance in patients with pancreatic ductal adenocarcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results